Table 3.
Three output examples from the testing set of histopathological tumour type classification on the BTM dataset. Ground truth (GT) is the pathological diagnosis made by clinicians.
| Sample ID | Rank | Class ID | Class Name (2016 WHO Classification of CNS Tumours) | Probability |
|---|---|---|---|---|
| GSM2941340 | 1st | 4 | Anaplastic ependymoma | 75.3695% |
| 2nd | 5 | Ependymoma | 21.5774% | |
| 3rd | 23 | Myxopapillary ependymoma | 0.0275% | |
| 4th | 62 | Anaplastic (malignant) meningioma | 0.0008% | |
| 5th | 31 | Atypical meningioma | 0.0004% | |
| GT | 4 | Anaplastic ependymoma | ||
| GSM2941792 | 1st | 6 | Anaplastic astrocytoma, IDH-mutant | 81.4425% |
| 2nd | 13 | Diffuse astrocytoma, IDH-mutant | 17.8859% | |
| 3rd | 15 | Oligodendroglioma, IDH-mutant and 1p/19q-codeleted | 0.4496% | |
| 4th | 10 | Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted | 0.1553% | |
| 5th | 54 | Anaplastic astrocytoma, IDH-wildtype | 0.0124% | |
| GT | 6 | Anaplastic astrocytoma, IDH-mutant | ||
| GSM2405444 | 1st | 0 | Glioblastoma, IDH-wildtype | 99.9995% |
| 2nd | 32 | Gliosarcoma, IDH-wildtype | 0.0001% | |
| 3rd | 44 | Anaplastic pilocytic astrocytoma | 0.0001% | |
| 4th | 52 | Anaplastic pilocytic astrocytoma (unresolved status) | 0.0001% | |
| 5th | 20 | Ganglioglioma | 0.0001% | |
| GT | 0 | Glioblastoma, IDH-wildtype |
The ground truth diagnoses were marked in bold.